269
Views
4
CrossRef citations to date
0
Altmetric
Original Research

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups

, & ORCID Icon
Pages 1419-1424 | Published online: 25 Mar 2021

References

  • Teede H , Misso M , Tassone EC , et al. Anti-Mullerian hormone in PCOS: a review informing international guidelines. Trends Endocrinol Metab . 2019;30(7):467–478. doi:10.1016/j.tem.2019.04.006 31160167
  • Broer SL , Broekmans FJ , Laven JS , et al. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update . 2014;20(5):688–701. doi:10.1093/humupd/dmu020 24821925
  • Pigny P , Merlen E , Robert Y , et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab . 2003;88(12):5957–5962. doi:10.1210/jc.2003-030727 14671196
  • Pellatt L , Hanna L , Brincat M , et al. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab . 2007;92(1):240–245. doi:10.1210/jc.2006-1582 17062765
  • Streuli I , Fraisse T , Pillet C , et al. Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril . 2008;90(2):395–400. doi:10.1016/j.fertnstert.2007.06.023 17919608
  • Geisthovel F . A comment on the European Society of Human Reproduction and Embryology American Society for Reproductive Medicine consensus of the polycystic ovarian syndrome. Reprod Biomed Online . 2003;7(6):602–605. doi:10.1016/S1472-6483(10)62081-0 14748954
  • Alebic MS , Stojanovic N , Duhamel A , et al. The phenotypic diversity in per-follicle anti-Mullerian hormone production in polycystic ovary syndrome. Hum Reprod . 2015;30(8):1927–1933. doi:10.1093/humrep/dev131 26048913
  • Pierre A , Taieb J , Giton F , et al. Dysregulation of the anti-Mullerian hormone system by steroids in women with polycystic ovary syndrome. J Clin Endocrinol Metab . 2017;102(11):3970–3978. doi:10.1210/jc.2017-00308 28938480
  • Cimino I , Casoni F , Liu X , et al. Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun . 2016;7:10055. doi:10.1038/ncomms10055 26753790
  • Lefebvre T , Dumont A , Pigny P , et al. Effect of obesity and its related metabolic factors on serum anti-Mullerian hormone concentrations in women with and without polycystic ovaries. Reprod Biomed Online . 2017;35(3):325–330. doi:10.1016/j.rbmo.2017.05.013 28624344
  • Simoes-Pereira J , Nunes J , Aguiar A , et al. Influence of body mass index in anti-Mullerian hormone levels in 951 non-polycystic ovarian syndrome women followed at a reproductive medicine unit. Endocrine . 2018;61(1):144–148. doi:10.1007/s12020-018-1555-y 29470775
  • Piouka A , Farmakiotis D , Katsikis I , et al. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab . 2009;296(2):E238–E243. doi:10.1152/ajpendo.90684.2008 18957615
  • Khashchenko E , Uvarova E , Vysokikh M , et al. The relevant hormonal levels and diagnostic features of polycystic ovary syndrome in adolescents. J Clin Med . 2020;9(6):1831. doi:10.3390/jcm9061831
  • Escobar-Morreale HF . Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol . 2018;14(5):270–284. doi:10.1038/nrendo.2018.24 29569621
  • Zijiang Chen QT . Guidelines for the diagnosis and treatment of polycystic ovary syndrome in China. Chin J Obstet Gynecol . 2018;53(01):2–6.
  • Bozdag G , Mumusoglu S , Coskun ZY , et al. Anti-Mullerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population. Reprod Biomed Online . 2019;39(3):522–529. doi:10.1016/j.rbmo.2019.04.002 31182353
  • Karakas SE . New biomarkers for diagnosis and management of polycystic ovary syndrome. Clin Chim Acta . 2017;471:248–253. doi:10.1016/j.cca.2017.06.009 28624501
  • Dumont A , Robin G , Dewailly D . Anti-mullerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome. Curr Opin Endocrinol Diabetes Obes . 2018;25(6):377–384. doi:10.1097/MED.0000000000000445 30299432
  • Teede HJ , Misso ML , Costello MF , et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod . 2018;33(9):1602–1618. doi:10.1093/humrep/dey256 30052961
  • Lv PP , Jin M , Rao JP , et al. Role of anti-Mullerian hormone and testosterone in follicular growth: a cross-sectional study. BMC Endocr Disord . 2020;20(1):101. doi:10.1186/s12902-020-00569-6 32641160
  • Sova H , Unkila-Kallio L , Tiitinen A , et al. Hormone profiling, including anti-Mullerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes. Gynecol Endocrinol . 2019;35(7):595–600. doi:10.1080/09513590.2018.1559807 30668196
  • Wiweko B , Maidarti M , Priangga MD , et al. Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients. J Assist Reprod Genet . 2014;31(10):1311–1316. doi:10.1007/s10815-014-0300-6 25119192
  • Jacob SL , Field HP , Calder N , et al. Anti-Mullerian hormone reflects the severity of polycystic ovary syndrome. Clin Endocrinol (Oxf) . 2017;86(3):395–400. doi:10.1111/cen.13269 27805276
  • Dewailly D , Andersen CY , Balen A , et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update . 2014;20(3):370–385. doi:10.1093/humupd/dmt062 24430863
  • Yue CY , Lu LK , Li M , et al. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women. PLoS One . 2018;13(8):e203129. doi:10.1371/journal.pone.0203129
  • Hart R , Doherty DA , Norman RJ , et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril . 2010;94(3):1118–1121. doi:10.1016/j.fertnstert.2009.11.002 20060112
  • Ranasinha S , Joham AE , Norman RJ , et al. The association between Polycystic Ovary Syndrome (PCOS) and metabolic syndrome: a statistical modelling approach. Clin Endocrinol (Oxf) . 2015;83(6):879–887. doi:10.1111/cen.12830 26052744
  • Jun TJ , Jelani AM , Omar J , et al. Serum anti-Mullerian hormone in polycystic ovary syndrome and its relationship with insulin resistance, lipid profile and adiponectin. Indian J Endocrinol Metab . 2020;24(2):191–195. doi:10.4103/ijem.IJEM_305_19 32699789
  • Li J , Wu Q , Wang CC , et al. Endocrine characteristics, body mass index and metabolic syndrome in women with polycystic ovary syndrome. Reprod Biomed Online . 2019;39(5):868–876. doi:10.1016/j.rbmo.2019.06.014 31444050
  • Merino PM , Villarroel C , Jesam C , et al. New diagnostic criteria of polycystic ovarian morphology for adolescents: impact on prevalence and hormonal profile. Horm Res Paediatr . 2017;88(6):401–407. doi:10.1159/000481532 29049986